Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

The Tumor Microenvironment as a Regulator of Endocrine Resistance in Breast Cancer.

Diaz Bessone MI, Gattas MJ, Laporte T, Tanaka M, Simian M.

Front Endocrinol (Lausanne). 2019 Aug 8;10:547. doi: 10.3389/fendo.2019.00547. eCollection 2019. Review.

2.

Fibronectin rescues estrogen receptor α from lysosomal degradation in breast cancer cells.

Sampayo RG, Toscani AM, Rubashkin MG, Thi K, Masullo LA, Violi IL, Lakins JN, Cáceres A, Hines WC, Coluccio Leskow F, Stefani FD, Chialvo DR, Bissell MJ, Weaver VM, Simian M.

J Cell Biol. 2018 Aug 6;217(8):2777-2798. doi: 10.1083/jcb.201703037. Epub 2018 Jul 6.

3.

Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands.

Carlini MJ, Recouvreux MS, Simian M, Nagai MA.

BMC Cancer. 2018 Jun 25;18(1):682. doi: 10.1186/s12885-018-4550-z.

4.

Human-specific approaches to brain research for the 21st century: a South American perspective.

Triunfol M, Rehen S, Simian M, Seidle T.

Drug Discov Today. 2018 Dec;23(12):1929-1935. doi: 10.1016/j.drudis.2018.06.001. Epub 2018 Jun 13.

5.

Angiotensin-(1-7) counteracts the transforming effects triggered by angiotensin II in breast cancer cells.

Cambados N, Walther T, Nahmod K, Tocci JM, Rubinstein N, Böhme I, Simian M, Sampayo R, Del Valle Suberbordes M, Kordon EC, Schere-Levy C.

Oncotarget. 2017 Jul 17;8(51):88475-88487. doi: 10.18632/oncotarget.19290. eCollection 2017 Oct 24.

6.

Distinct ErbB2 receptor populations differentially interact with beta1 integrin in breast cancer cell models.

Toscani AM, Sampayo RG, Barabas FM, Fuentes F, Simian M, Coluccio Leskow F.

PLoS One. 2017 Mar 17;12(3):e0174230. doi: 10.1371/journal.pone.0174230. eCollection 2017.

7.

Laminin Modulates the Stem Cell Population in LM05-E Murine Breast Cancer Cells through the Activation of the MAPK/ERK Pathway.

Berardi DE, Raffo D, Todaro LB, Simian M.

Cancer Res Treat. 2017 Oct;49(4):869-879. doi: 10.4143/crt.2016.378. Epub 2016 Dec 6.

8.

Organoids: A historical perspective of thinking in three dimensions.

Simian M, Bissell MJ.

J Cell Biol. 2017 Jan 2;216(1):31-40. doi: 10.1083/jcb.201610056. Epub 2016 Dec 28. Review.

9.

The combination of bleomycin with suicide or interferon-β gene transfer is able to efficiently eliminate human melanoma tumor initiating cells.

Fondello C, Agnetti L, Villaverde MS, Simian M, Glikin GC, Finocchiaro LME.

Biomed Pharmacother. 2016 Oct;83:290-301. doi: 10.1016/j.biopha.2016.06.038. Epub 2016 Jul 8.

PMID:
27399807
10.

Reversal of the Migratory and Invasive Phenotype of Ras-Transfected Mammary Cells by Photodynamic Therapy Treatment.

Calvo G, Sáenz D, Simian M, Sampayo R, Mamone L, Vallecorsa P, Batlle A, Casas A, Di Venosa G.

J Cell Biochem. 2017 Mar;118(3):464-477. doi: 10.1002/jcb.25657. Epub 2016 Jul 29.

PMID:
27438675
11.

AhR ligand Aminoflavone inhibits α6-integrin expression and breast cancer sphere-initiating capacity.

Brantley E, Callero MA, Berardi DE, Campbell P, Rowland L, Zylstra D, Amis L, Yee M, Simian M, Todaro L, Loaiza-Perez AI, Soto U.

Cancer Lett. 2016 Jun 28;376(1):53-61. doi: 10.1016/j.canlet.2016.03.025. Epub 2016 Mar 17.

PMID:
26996297
12.

Microenvironment and endocrine resistance in breast cancer: Friend or foe?

Recouvreux S, Sampayo R, Bessone MI, Simian M.

World J Clin Oncol. 2015 Dec 10;6(6):207-11. doi: 10.5306/wjco.v6.i6.207.

13.

Non-genomic actions of estradiol and 4-OH-tamoxifen on murine breast cancer cells.

Raffo D, Pontiggia O, Bal de Kier Joffé E, Simian M.

Oncol Rep. 2015 Jan;33(1):439-47. doi: 10.3892/or.2014.3558. Epub 2014 Oct 22.

PMID:
25338647
14.

Tamoxifen selects for breast cancer cells with mammosphere forming capacity and increased growth rate.

Raffo D, Berardi DE, Pontiggia O, Todaro L, de Kier Joffé EB, Simian M.

Breast Cancer Res Treat. 2013 Dec;142(3):537-48. doi: 10.1007/s10549-013-2760-2. Epub 2013 Nov 21.

PMID:
24258256
15.

The hyperplastic phenotype in PR-A and PR-B transgenic mice: lessons on the role of estrogen and progesterone receptors in the mouse mammary gland and breast cancer.

Sampayo R, Recouvreux S, Simian M.

Vitam Horm. 2013;93:185-201. doi: 10.1016/B978-0-12-416673-8.00012-5. Review.

PMID:
23810007
16.

AT1 receptor blockade delays postlactational mammary gland involution: a novel role for the renin angiotensin system.

Nahmod KA, Walther T, Cambados N, Fernandez N, Meiss R, Tappenbeck N, Wang Y, Raffo D, Simian M, Schwiebs A, Pozner RG, Fuxman Bass JI, Pozzi AG, Geffner JR, Kordon EC, Schere-Levy C.

FASEB J. 2012 May;26(5):1982-94. doi: 10.1096/fj.11-191932. Epub 2012 Jan 27.

PMID:
22286690
17.

The tumor microenvironment modulates tamoxifen resistance in breast cancer: a role for soluble stromal factors and fibronectin through β1 integrin.

Pontiggia O, Sampayo R, Raffo D, Motter A, Xu R, Bissell MJ, Joffé EB, Simian M.

Breast Cancer Res Treat. 2012 Jun;133(2):459-71. doi: 10.1007/s10549-011-1766-x. Epub 2011 Sep 21.

18.

In vitro studies of cellular response to DNA damage induced by boron neutron capture therapy.

Perona M, Pontiggia O, Carpano M, Thomasz L, Thorp S, Pozzi E, Simian M, Kahl S, Juvenal G, Pisarev M, Dagrosa A.

Appl Radiat Isot. 2011 Dec;69(12):1732-6. doi: 10.1016/j.apradiso.2011.03.044. Epub 2011 Apr 8.

PMID:
21530283
19.

Role of MMPs in metastatic dissemination: implications for therapeutic advances.

Raffo D, Pontiggia O, Simian M.

Curr Pharm Biotechnol. 2011 Nov;12(11):1937-47. Review.

PMID:
21470127
20.

Estrogen receptor β and epidermal growth factor receptor as early-stage prognostic biomarkers of non-small cell lung cancer.

Mauro LV, Dalurzo M, Carlini MJ, Smith D, Nuñez M, Simian M, Lastiri J, Vasallo B, Bal de Kier Joffé E, Pallotta MG, Puricelli L.

Oncol Rep. 2010 Nov;24(5):1331-8.

PMID:
20878128
21.

2-C-methyluridine modified hammerhead ribozyme against the estrogen receptor.

Pontiggia R, Pontiggia O, Simian M, Montserrat JM, Engels JW, Iribarren AM.

Bioorg Med Chem Lett. 2010 May 1;20(9):2806-8. doi: 10.1016/j.bmcl.2010.03.060. Epub 2010 Mar 17.

PMID:
20362443
22.

Estrogen and progesterone receptors have distinct roles in the establishment of the hyperplastic phenotype in PR-A transgenic mice.

Simian M, Bissell MJ, Barcellos-Hoff MH, Shyamala G.

Breast Cancer Res. 2009;11(5):R72. doi: 10.1186/bcr2408.

23.

Decreased metastatic phenotype in cells resistant to aminolevulinic acid-photodynamic therapy.

Casas A, Di Venosa G, Vanzulli S, Perotti C, Mamome L, Rodriguez L, Simian M, Juarranz A, Pontiggia O, Hasan T, Batlle A.

Cancer Lett. 2008 Nov 28;271(2):342-51. doi: 10.1016/j.canlet.2008.06.023. Epub 2008 Jul 26.

24.

Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal-epithelial interactions.

Pontiggia O, Rodriguez V, Fabris V, Raffo D, Bumaschny V, Fiszman G, de Kier Joffé EB, Simian M.

Breast Cancer Res Treat. 2009 Jul;116(2):247-55. doi: 10.1007/s10549-008-0113-3. Epub 2008 Jul 12.

PMID:
18622696
25.

A spontaneous estrogen dependent, tamoxifen sensitive mouse mammary tumor: a new model system to study hormone-responsiveness in immune competent mice.

Simian M, Manzur T, Rodriguez V, de Kier Joffé EB, Klein S.

Breast Cancer Res Treat. 2009 Jan;113(1):1-8. doi: 10.1007/s10549-007-9888-x. Epub 2008 Jan 9.

PMID:
18183485
26.
27.

Isolation of a stromal cell line from an early passage of a mouse mammary tumor line: a model for stromal parenchymal interactions.

Lamb CA, Fabris V, Gorostiaga MA, Helguero LA, Efeyan A, Bottino MC, Simian M, Soldati R, Sanjuan N, Molinolo A, Lanari C.

J Cell Physiol. 2005 Mar;202(3):672-82.

PMID:
15389583
28.

[About the death of Herod the Great].

Espinoza R, Sepúlveda C, Vukusich C, Fantuzzi A, Serrano M, Simian M.

Rev Med Chil. 2003 May;131(5):569-72. Spanish.

PMID:
12879820
29.

The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells.

Simian M, Hirai Y, Navre M, Werb Z, Lochter A, Bissell MJ.

Development. 2001 Aug;128(16):3117-31.

30.

Epimorphin mediates mammary luminal morphogenesis through control of C/EBPbeta.

Hirai Y, Radisky D, Boudreau R, Simian M, Stevens ME, Oka Y, Takebe K, Niwa S, Bissell MJ.

J Cell Biol. 2001 May 14;153(4):785-94.

31.

Nidogen-1 regulates laminin-1-dependent mammary-specific gene expression.

Pujuguet P, Simian M, Liaw J, Timpl R, Werb Z, Bissell MJ.

J Cell Sci. 2000 Mar;113 ( Pt 5):849-58.

32.
33.

Involvement of insulin-like growth factors-I and -II and their receptors in medroxyprogesterone acetate-induced growth of mouse mammary adenocarcinomas.

Elizalde PV, Lanari C, Molinolo AA, Guerra FK, Balañá ME, Simian M, Iribarren AM, Charreau EH.

J Steroid Biochem Mol Biol. 1998 Nov;67(4):305-17.

PMID:
9883987
34.

Involvement of EGF in medroxyprogesterone acetate (MPA)-induced mammary gland hyperplasia and its role in MPA-induced mammary tumors in BALB/c mice.

Molinolo A, Simian M, Vanzulli S, Pazos P, Lamb C, Montecchia F, Lanari C.

Cancer Lett. 1998 Apr 10;126(1):49-57.

PMID:
9563648
35.

[Progestin-induced mammary adenocarcinomas in BALB/c mice. Progression from hormone-dependent to autonomous tumors].

Lanari C, Montecchia MF, Pazos P, Simian M, Vanzulli S, Lamb C, Molinolo AA.

Medicina (B Aires). 1997;57 Suppl 2:55-69. Spanish.

PMID:
9567344

Supplemental Content

Loading ...
Support Center